본문 바로가기
KERD
논문KCI 등재

Clinical Biomarkers of Neurodegeneration in REM Sleep Behavior Disorder

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Rapid eye movement (REM) sleep behavior disorder (RBD) is currently considered as a prodromal stage of α -synucleinopathies neurodegeneration. The update data suggested that over 80% patients with idiopathic RBD eventually developed neurodegenerative disease after a mean of 14 years interval from the onset of RBD. A series of potential biomarkers have been identified to predict the development of neurodegeneration in idiopathic RBD, including olfactory loss, color vision deficit, depression, mild cognitive impairment, excessive daytime sleepiness, dopamine dysfunction, and tonic EMG activity. Early recognition of the predictive markers of neurodegeneration in idiopathic RBD is essential for development of intervention or prevention strategies at the presymptomatic stage. Nonetheless, the current literature is lacking biomarkers that might reflect the α-synuclein neuropathology at the earliest stages. Future studies with large samples and systematic follow-up are needed to confirm more potential markers of neurodegeneration at its early stages.

Abstract

Rapid eye movement (REM) sleep behavior disorder (RBD) is currently considered as a prodromal stage of α -synucleinopathies neurodegeneration. The update data suggested that over 80% patients with idiopathic RBD eventually developed neurodegenerative disease after a mean of 14 years interval from the onset of RBD. A series of potential biomarkers have been identified to predict the development of neurodegeneration in idiopathic RBD, including olfactory loss, color vision deficit, depression, mild cognitive impairment, excessive daytime sleepiness, dopamine dysfunction, and tonic EMG activity. Early recognition of the predictive markers of neurodegeneration in idiopathic RBD is essential for development of intervention or prevention strategies at the presymptomatic stage. Nonetheless, the current literature is lacking biomarkers that might reflect the α-synuclein neuropathology at the earliest stages. Future studies with large samples and systematic follow-up are needed to confirm more potential markers of neurodegeneration at its early stages.

참고문헌 (80)

  1. American Academy of Sleep Medicine, "International Classification of Sleep Disorders: Diagnostic and Coding manual", American Academy of Sleep Medicine, ~ (2005)
  2. Schenck CH, "Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder", Neurology, 46, pp.388~393 (1996)
  3. Boeve BF, "Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy", Mov Disord, 16, pp.622~630 (2001)
  4. Postuma RB, "Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder", Neurology, 72, pp.1296~1300 (2009)
  5. Iranzo A, "Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis", Ann Neurol, 59, pp.178~181 (2006)
  6. Schenck CH, "Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder : a 16-year update on a previously reported series", Sleep Med, 14, pp.744~748 (2013)
  7. Postuma RB, "Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease", Brain, 132(Pt 12), pp.3298~3307 (2009)
  8. Jennum P, "Morbidities in rapid eye movement sleep behavior disorder", Sleep Med, 14, pp.782~787 (2013)
  9. Iranzo A, "Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder : a descriptive study", Lancet Neurol, 5, pp.572~577 (2006)
  10. Wing YK, "Prospective outcome of rapid eye movement sleep behaviour disorder : psychiatric disorders as a potential early marker of Parkinson’s disease", J Neurol Neurosurg Psychiatry, 83, pp.470~472 (2012)
  11. Bernheimer H, "Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations", J Neurol Sci, 20, pp.415~455 (1973)
  12. Haehner A, "Prevalence of smell loss in Parkinson’s disease--a multicenter study", Parkinsonism Relat Disord, 15, pp.490~494 (2009)
  13. Ross GW, "Association of olfactory dysfunction with risk for future Parkinson’s disease", Ann Neurol, 63, pp.167~173 (2008)
  14. Fantini ML, "Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder", Brain Res Bull, 70, pp.386~390 (2006)
  15. Mahlknecht P, "Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD", Neurology, 84, pp.654~658 (2015)
  16. Zesiewicz TA, "Autonomic Nervous System Dysfunction in Parkinson’s Disease", Curr Treat Options Neurol, 5, pp.149~160 (2003)
  17. Micieli G, "Autonomic dysfunction in Parkinson’s disease", Neurol Sci, 24(Suppl 1), pp.S32~S34 (2003)
  18. Braak H, "Invited Article: Nervous system pathology in sporadic Parkinson disease", Neurology, 70, pp.1916~1925 (2008)
  19. Braak H, "Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons", Acta Neuropathol, 113, pp.421~429 (2007)
  20. Braak H, "Staging of brain pathology related to sporadic Parkinson’s disease", Neurobiol Aging, 24, pp.197~211 (2003)
  21. Palma JA, "Autonomic disorders predicting Parkinson’s disease", Parkinsonism Relat Disord, 20(Suppl 1), pp.S94~S98 (2014)
  22. Lanfranchi PA, "Cardiac autonomic regulation during sleep in idiopathic REM sleep behavior disorder", Sleep, 30, pp.1019~1025 (2007)
  23. Ferini-Strambi L, "Cardiac autonomic activity during wakefulness and sleep in REM sleep behavior disorder", Sleep, 19, pp.367~369 (1996)
  24. Miyamoto T, "Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder", Neurology, 67, pp.2236~2238 (2006)
  25. Postuma RB, "Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder", Mov Disord, 25, pp.2304~2310 (2010)
  26. Postuma RB, "Parkinson risk in idiopathic REM sleep behavior disorder : preparing for neuroprotective trials", Neurology, 84, pp.1104~1113 (2015)
  27. Oh YS, "Color vision in Parkinson’s disease and essential tremor", Eur J Neurol, 18, pp.577~583 (2011)
  28. Postuma RB, "Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder", Neurology, 66, pp.845~851 (2006)
  29. Foltynie T, "The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study", Brain, 127(Pt 3), pp.550~560 (2004)
  30. Pfeiffer HC, "Cognitive impairment in early-stage non-demented Parkinson’s disease patients", Acta Neurol Scand, 129, pp.307~318 (2014)
  31. Aarsland D, "Risk of dementia in Parkinson’s disease: a community-based, prospective study", Neurology, 56, pp.730~736 (2001)
  32. Mahieux F, "Neuropsychological prediction of dementia in Parkinson’s disease", J Neurol Neurosurg Psychiatry, 64, pp.178~183 (1998)
  33. Levy G, "Memory and executive function impairment predict dementia in Parkinson’s disease", Mov Disord, 17, pp.1221~1226 (2002)
  34. Janvin CC, "Cognitive predictors of dementia in Parkinson’s disease: a community-based, 4-year longitudinal study", J Geriatr Psychiatry Neurol, 18, pp.149~154 (2005)
  35. Marques A, "REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream?", J Neurol, 257, pp.383~391 (2010)
  36. Massicotte-Marquez J, "Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder", Neurology, 70, pp.1250~1257 (2008)
  37. Ferini-Strambi L, "Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist?", Neurology, 62, pp.41~45 (2004)
  38. Levin BE, "Visuospatial impairment in Parkinson’s disease", Neurology, 41, pp.365~369 (1991)
  39. McKeith IG, "Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium", Neurology, 65, pp.1863~1872 (2005)
  40. Fantini ML, "Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder", Sleep, 34, pp.619~625 (2011)
  41. Terzaghi M, "Cognitive performances and mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder : results of a longitudinal follow-up study", Sleep, 36, pp.1527~1532 (2013)
  42. Molano J, "Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study", Brain, 133(Pt 2), pp.540~556 (2010)
  43. Youn S, "Progression of cognitive impairments in idiopathic REM sleep behaviour disorder", J Neurol Neurosurg Psychiatry (2015)[DOI]
  44. Hobson DE, "Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group", JAMA, 287, pp.455~463 (2002)
  45. Gjerstad MD, "Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?", Neurology, 67, pp.853~858 (2006)
  46. Tholfsen LK, "Development of excessive daytime sleepiness in early Parkinson disease", Neurology, 85, pp.162~168 (2015)
  47. Diederich NJ, "Sleep disorders in Parkinson’s disease: many causes, few therapeutic options", J Neurol Sci, 314, pp.12~19 (2012)
  48. Abbott RD, "Excessive daytime sleepiness and subsequent development of Parkinson disease", Neurology, 65, pp.1442~1446 (2005)
  49. Arnulf I, "Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease", Sleep, 38, pp.1529~1535 (2015)
  50. Arnulf I, "Sleepiness in Parkinson’s disease", Parkinsonism Relat Disord, 15(Suppl 3), pp.S101~S104 (2009)
  51. Unger MM, "Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions", Sleep, 33, pp.767~773 (2010)
  52. Cummings JL, "Depression and Parkinson’s disease: a review", Am J Psychiatry, 149, pp.443~454 (1992)
  53. Nilsson FM, "Increased risk of developing Parkinson’s disease for patients with major affective disorder : a register study", Acta Psychiatr Scand, 104, pp.380~386 (2001)
  54. Wing YK, "Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression", Neurology, 84, pp.516~522 (2015)
  55. Voon V, "Medication-related impulse control and repetitive behaviors in Parkinson disease", Arch Neurol, 64, pp.1089~1096 (2007)
  56. Weintraub D, "Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients", Arch Neurol, 67, pp.589~595 (2010)
  57. Arnulf I., "REM sleep behavior disorder: motor manifestations and pathophysiology", Mov Disord, 27, pp.677~689 (2012)
  58. Fantini ML, "Increased risk of impulse control symptoms in Parkinson’s disease with REM sleep behaviour disorder", J Neurol Neurosurg Psychiatry, 86, pp.174~179 (2015)
  59. Ishihara L, "What is the evidence for a premorbid parkinsonian personality : a systematic review", Mov Disord, 21, pp.1066~1072 (2006)
  60. Menza MA, "Dopamine-related personality traits in Parkinson’s disease", Neurology, 43(3 Pt 1), pp.505~508 (1993)
  61. Fujii C, "Cross-cultural traits for personality of patients with Parkinson’s disease in Japan", Am J Med Genet, 96, pp.1~3 (2000)
  62. Ward CD, "Parkinson’s disease in twins", Adv Neurol, 40, pp.341~344 (1984)
  63. Hubble JP, "Personality and depression in Parkinson’s disease", J Nerv Ment Dis, 181, pp.657~662 (1993)
  64. Menza MA, "Parkinson’s disease, personality, and dopamine", J Neuropsychiatry Clin Neurosci, 2, pp.282~287 (1990)
  65. Sieurin J, "Personality traits and the risk for Parkinson disease: a prospective study", Eur J Epidemiol (2015)[DOI]
  66. Troiano AR, "PET demonstrates reduced dopamine transporter expression in PD with dyskinesias", Neurology, 72, pp.1211~1216 (2009)
  67. Thobois S, "PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences", Neuroimage, 23, pp.1~16 (2004)
  68. "Lancet Neurol", 2010, 1070~1077
  69. Kim YK, "The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder", Eur J Neurol, 17, pp.487~492 (2010)
  70. Rupprecht S, "Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder", Sleep Med, 14, pp.1064~1070 (2013)
  71. Stiasny-Kolster K, "Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT", Brain, 128(Pt 1), pp.126~137 (2005)
  72. Eisensehr I, "Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson’s disease and controls", Brain, 123(Pt 6), pp.1155~1160 (2000)
  73. Arnaldi D, "Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?", Neurobiol Aging, 36, pp.3300~3305 (2015)
  74. Brücke T, "SPECT and PET imaging of the dopaminergic system in Parkinson’s disease", J Neurol, 247(Suppl 4), pp.IV (2000), 2~IV[DOI]
  75. Boeve BF, "Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease", Brain, 130(Pt 11), pp.2770~2788 (2007)
  76. Iranzo A, "Excessive muscle activity increases over time in idiopathic REM sleep behavior disorder", Sleep, 32, pp.1149~1153 (2009)
  77. Postuma RB, "Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease", Neurology, 74, pp.239~244 (2010)
  78. Eisensehr I, "Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls", Sleep, 26, pp.507~512 (2003)
  79. Pont-Sunyer C, "The onset of nonmotor symptoms in Parkinson’s disease(the ONSET PD study)", Mov Disord, 30, pp.229~237 (2015)
  80. Postuma RB, "Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder", Ann Neurol, 69, pp.811~818 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (8건)